Navigation Links
Digoxin Pill To Fight Against Both Heart Diseases And Cancer

The Drug Digoxin or Digitalis, which comes from the foxglove plant, is normally used to help the heart beat efficiently by maintaining the rhythm of the heart and treat heart diseases. The chemical nature of the drug is changed by the team of researchers from University of Wisconsin-Madison to make the drug fight against cancer//.

This technique is called as neo (new)-glyco (sugar)-randomisation, which works by changing the sugars attached to the drug. By changing the way the sugars are grouped on a drug, it changes the way how the drug works. By switching the sugars in digitalis it was possible to boost the ability of the drug to target cancer cells and kill them. By using this technique of neoglycorandomisation it is possible to develop drugs for other disease. It is possible to manipulate the drug for treatment of different diseases.

Dr. Hazel Nunn of Cancer Research has said, "We've already taken this chemistry and applied it to many different classes and it is possible to extend it to antibiotics and antivirals. If you want to plug a sugar and see what it does for you, this is the best way to do it.

This technique is an important biomedical advance, which could increase the chances of finding active drugs against cancer and a wide range of other conditions.

Any drug developed using this technique will need to go through rigorous clinical trials to determine their safety and effectiveness in humans.

Source: BBC News
'"/>




Page: 1

Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Fight against E.coli
6. Red Wine Helps Fight Heart disease
7. Fish Oil Fights Arrhythmias, Sudden Death
8. SARS-Free Taiwan to Mark End Phase of Global Fight
9. Few Parents Help Kids Fight Acne
10. Common Cold Found to Fight Cancer
11. The Possibility Of Fighting HIV with Another Virus Questioned
Post Your Comments:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator 47491 1Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator 47491 2Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 1Findings in epilepsy gene in animals may guide treatment directions for infants 47484 2Findings in epilepsy gene in animals may guide treatment directions for infants 47484 3